CJC-1295 with DAC — Powder

CJC-1295 with DAC Lyophilized Powder – Vial – Research Use Only

CJC-1295 with DAC is a long-acting synthetic analogue of growth hormone-releasing hormone (GHRH) that incorporates a Drug Affinity Complex (DAC) to extend its half-life significantly. It is supplied as a lyophilized powder in a sealed research vial and is studied for its ability to produce sustained elevations in growth hormone and IGF-1 levels.

In laboratory settings, researchers examine how the DAC technology allows CJC-1295 to bind to serum albumin, dramatically extending its active duration compared to native GHRH or CJC-1295 No DAC, enabling less frequent dosing in research protocols.

Researchers commonly study CJC-1295 with DAC to explore its potential involvement in:

• Sustained growth hormone and IGF-1 elevation
• Lean muscle mass development and anabolic signaling
• Fat metabolism and body composition research
• Bone density and skeletal health mechanisms
• Sleep quality and restorative processes
• Age-related GH decline and somatopause research
• Long-acting GHRH analogue pharmacokinetics

As a long-acting GHRH analogue, CJC-1295 with DAC serves as a valuable research tool for investigating sustained growth hormone secretion, endocrine signaling, and anabolic processes in controlled laboratory environments.

📄 Read the Full Research Overview →

For laboratory research use only. Not for human or veterinary, diagnostic, or therapeutic use.

Technical Specifications

• Chemical Name: CJC-1295 with DAC
• Form: Lyophilized powder
• Appearance: White to off-white powder
• Purity: ≥98% (HPLC) – COA available upon request

Storage: Store at -20°C or lower, protected from light and moisture. Reconstitute using standard laboratory peptide protocols.

Category: Lyophilized Vial

Research Use Only. Not for human consumption. For laboratory, in vitro, or scientific research by qualified professionals only.